Shares of Pfizer and BioNTech fell 1.74% and 2% (respectively) on Thursday amid news that companies will deliver half of their planned number of vaccines against COVID-19 in 2020. On November 20, Pfizer and its German partner BioNTech applied to the FDA (US Food and Drug Administration) for permission to use their vaccine in an […]
Shares of the largest US pharmaceutical company Pfizer, down to 3.14% since the beginning of the year, rose to 3.83% on Friday on good news about its vaccine against the COVID-19. Currently, the mTNA candidate vaccine of BNT162b1, developed by Pfizer in the partnership with the German company BioNTech, the mechanism of the action of […]
Shares of the Johnson & Johnson may slow because the last stimulus to it was the company’s transition to the final clinical trial of the vaccine against COVID-19 on September 23, after which the shares rose by more than 5%. However, as of Tuesday, before the opening of trading, the price of J&J shares did […]
Two scientists from Lviv won the competition of projects of the National Research Fund of Ukraine. They will be provided with funds for developing a vaccine against the corona virus COVID-19, as well as to create a new generation of antibiotics. This was announced on Wednesday, September 9, by the head of the Lviv Regional […]
Half of the 2 billion doses of coronavirus vaccine that the American company Novavax intends to develop, will be manufactured at its Czech plant Praha Vaccines, said on Tuesday at a press conference the Prime Minister of the Czech Republic Andrej Babiš, who visited this enterprise near Prague. “Novavax wants to produce 2 billion coronavirus […]
Shares of Moderna that up to 252.6% since the beginning of the year, increased by 9% before the opening of trading on Wednesday against the backdrop of President Donald Trump signing a major government agreement with the company to supply 100 million doses of its mRNA-1273 vaccine against COVID-19. According to a Moderna press release […]
Pfizer and BioNTech shares rose sharply on Monday by 4% and 10%, respectively. This happened after the US Food and Drug Administration (FDA) assigned an “accelerated” status to their two COVID-19 potential vaccines. Although the companies have not yet completed the final tests and have not received approval for the production and sale of their […]